908 Devices Reports 21% Q4 Revenue Growth, Achieves Positive Adjusted EBITDA
MASS has more than doubled off its 52-week low of $1.92.
Summary
908 Devices Inc. reported strong fourth quarter and full-year 2025 financial results, highlighted by a significant operational turnaround. Fourth-quarter revenue increased 21% year-over-year to $17.4 million, contributing to an 18% full-year revenue growth to $56.2 million. Crucially, the company achieved positive Adjusted EBITDA of $0.7 million and net income from continuing operations of $4.4 million in Q4 2025, a substantial improvement from prior-year losses. This shift to profitability, coupled with robust revenue growth and a strong cash position of $113.0 million, signals improved operational efficiency and market demand for its chemical analysis tools. The company also provided its 2026 revenue outlook, which will be a key factor for future investor sentiment and valuation.
At the time of this announcement, MASS was trading at $6.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $239.2M. The 52-week trading range was $1.92 to $9.34. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.